Palvella Therapeutics (PVLA)
Develops topical QTORIN candidates for serious rare skin diseases and vascular malformations.
$149.05
vs last close−9.08 (−5.74%)
Something off on this page? Send us feedback.
Next report
Nov 10, 26
in 48 days
EPS estimate
−$1.80
Revenue estimate
$16.7K
Fiscal quarter
Q3 FY26
EPSReportedEstimate
Mar '25May '25Aug '25Nov '25Mar '26May '26Aug '26Nov '26
Reported$4.00−$0.74−$0.86−$1.03−$1.08−$1.20−$1.52Pending
Estimate−$0.39−$3.40−$0.78−$0.85−$0.91−$0.90−$1.17−$1.80
Surprise+1,125.6%+78.2%−10.3%−21.2%−18.5%−33.3%−29.9%—
RevenueReportedEstimate
Mar '25May '25Aug '25Nov '25Mar '26May '26Aug '26Nov '26
Reported———————Pending
Estimate———————$16.7K
Surprise————————
HistoryUpcoming
| Date / Period | Estimate | Reported | Surprise |
|---|---|---|---|
| Dec 2027 | −$1.75 | — | — |
| Sep 2027 | −$3.00 | — | — |
| Jun 2027 | −$2.81 | — | — |
| Mar 2027 | −$2.48 | — | — |
| Dec 2026 | −$2.15 | — | — |
| Nov 2026 | −$1.80 | — | — |
| Aug 2026 | −$1.17 | −$1.52 | −29.9% |
| May 2026 | −$0.90 | −$1.20 | −33.3% |
| Mar 2026 | −$0.91 | −$1.08 | −18.5% |
| Nov 2025 | −$0.85 | −$1.03 | −21.2% |
| Aug 2025 | |||
| May 2025 | |||
| Mar 2025 | |||
| Nov 2024 | |||
| Aug 2024 | |||
| May 2024 | |||
| Mar 2024 | |||
| Nov 2023 | |||
| Aug 2023 | |||
| May 2023 |
| Date / Period | EPS est | EPS | Surprise | Revenue est | Revenue | Surprise | Reaction |
|---|---|---|---|---|---|---|---|
| Dec 2027 | −$1.75 | — | — | $13.1M | — | — | — |
| Sep 2027 | −$3.00 | — | — | $3.0M | — | — | — |
| Jun 2027 | −$2.81 | — | — | $0 | — | — | — |
| Mar 2027 | −$2.48 | — | — | $0 | — | — | — |
| Dec 2026 | −$2.15 | — | — | $16.7K | — | — | — |
| Nov 10, 2026 | −$1.80 | — | — | $16.7K | — | — | — |
| Aug 4, 2026 | −$1.17 | −$1.52 | −29.9% | — | — | — | +8.0% |
| May 7, 2026 | −$0.90 | −$1.20 | −33.3% | — | — | — | −13.0% |
| Mar 31, 2026 | −$0.91 | −$1.08 | −18.5% | — | — | — | +12.6% |
| Nov 11, 2025 | −$0.85 | −$1.03 | −21.2% | — | — | — | −3.0% |
| Aug 14, 2025 | |||||||
| May 15, 2025 | |||||||
| Mar 31, 2025 | |||||||
| Nov 13, 2024 | |||||||
| Aug 14, 2024 | |||||||
| May 16, 2024 | |||||||
| Mar 30, 2024 | |||||||
| Nov 15, 2023 | |||||||
| Aug 11, 2023 | |||||||
| May 10, 2023 |